FDA panel says Vertex/CRISPR to assess safety risks of gene therapy in follow-up study
A panel of advisers to the U.S. health regulator said on Tuesday Vertex Pharmaceuticals and CRISPR Therapeutics could
2023-11-01 07:58
Nvidia invests $50 million in Recursion to train AI models for drug discovery
(Reuters) -Nvidia invested $50 million to speed up training of biotech firm Recursion's artificial intelligence models for drug discovery, which
2023-07-12 20:52